Poolbeg Pharma PLC (AIM:POLB)
London
· Delayed Price · Currency is GBP · Price in GBX 4.171
-0.029 (-0.69%)
Mar 6, 2026, 3:13 PM GMT
Poolbeg Pharma Market Cap
Poolbeg Pharma has a market cap or net worth of 29.61 million as of March 6, 2026. Its market cap has increased by 48.07% in one year.
Market Cap
29.61M
Enterprise Value
19.65M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
4.17
Market Cap Chart
Since July 19, 2021, Poolbeg Pharma's market cap has decreased from 53.75M to 29.61M, a decrease of -44.90%. That is a compound annual growth rate of -12.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 29.61M | 6.19% |
| Dec 31, 2025 | 27.89M | -21.44% |
| Dec 31, 2024 | 35.50M | -21.55% |
| Dec 29, 2023 | 45.25M | 49.59% |
| Dec 30, 2022 | 30.25M | -36.32% |
| Dec 31, 2021 | 47.50M | -11.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arecor Therapeutics | 27.18M |
| ImmuPharma | 34.94M |
| SkinBioTherapeutics | 24.78M |
| Aptamer Group | 22.92M |
| Sareum Holdings | 21.40M |
| Fusion Antibodies | 17.50M |
| Ondine Biomedical | 53.25M |
| hVIVO | 55.11M |